lactose monohydrate - 100,00 mg/tablet cellulose microcrystalline - 95,60 mg/tablet Croscarmellose sodium - 2,00 mg/tablet Magnesium stearate - 2,40 mg/tablet table coating - OPADRY 20A82938 Yellow - COLORCON, Asmenol, 10 mg, tabletki powlekane
CADET-PAD
Phase 3 small_molecule active
Quick answer
lactose monohydrate - 100,00 mg/tablet cellulose microcrystalline - 95,60 mg/tablet Croscarmellose sodium - 2,00 mg/tablet Magnesium stearate - 2,40 mg/tablet table coating - OPADRY 20A82938 Yellow - COLORCON, Asmenol, 10 mg, tabletki powlekane for Ischemia of the lower limbs in the course of obstructive artery disease is a Phase 3 program (small_molecule) at COLLEGIUM PHARMACEUTICAL, INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- COLLEGIUM PHARMACEUTICAL, INC
- Indication
- Ischemia of the lower limbs in the course of obstructive artery disease
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active